📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Molecular Assemblies

1.1 - Company Overview

Molecular Assemblies Logo

Molecular Assemblies

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of proprietary Fully Enzymatic Synthesis (FES) technology to produce long, pure, accurate DNA up to 400 nucleotides without post-synthesis purification; custom DNA oligos for CRISPR, cloning and NGS; gene editing, protein engineering and gene assembly services; and a partnering program licensing FES for on-site synthesis with an automated platform, proprietary reagents and research-use licenses.

Products and services

  • Fully Enzymatic Synthesis (FES) Technology: Proprietary enzymatic DNA synthesis that constructs long, pure, accurate sequences up to 400 nucleotides and eliminates the need for post-synthesis purification
  • Partnering Program: Research-use-only licensing that supplies an automated synthesis platform, proprietary reagents, and necessary licenses for on-site FES-based DNA synthesis at partner facilities
  • Custom DNA Oligos: Custom-engineered single-stranded oligonucleotides up to 400 nucleotides, suitable for CRISPR gene editing, molecular cloning, and next-generation sequencing probes and controls

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Molecular Assemblies

Nightingale Health Logo

Nightingale Health

HQ: Finland Website
  • Description: Provider of pioneering blood-testing services and proprietary blood analysis technology that delivers deep health insights, identifies disease risks from a single sample, and measures the effects of lifestyle interventions. Offers Nightingale Pro data platform for detecting population-level disease risks and preventative health needs, and biomarker analysis services for researchers across blood, urine, and dried blood spot samples.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nightingale Health company profile →
Constellation Pharmaceuticals Logo

Constellation Pharmaceuticals

HQ: United States Website
  • Description: Provider of novel therapeutics in the emerging field of epigenetics, focusing on selective regulators of epigenetic function critical to controlling gene expression; the first biopharmaceutical company dedicated to this area.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Constellation Pharmaceuticals company profile →
BC Platforms Logo

BC Platforms

HQ: Switzerland Website
  • Description: Provider of data and technology platforms for life sciences and healthcare, enabling access, management, and analysis of clinical, genomic, and omics data. Offers a federated Global Data Network, secure data environments, analytics and AI/federated analytics, and scientific services supporting pharmaceutical research, clinical trials, and real-world data studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BC Platforms company profile →
Sangamo Therapeutics Logo

Sangamo Therapeutics

HQ: United States Website
  • Description: Provider of engineered DNA-binding protein-based therapeutics, conducting clinical trials of gene and cell therapy candidates including: giroctocogene fitelparvovec for hemophilia A; ST-920 for Fabry disease; TX200 for patients undergoing a kidney transplant; SB-525/giroctocogene fitelparvovec (Phase 1/2); and BIVV003 ex vivo cell therapy for severe sickle cell disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sangamo Therapeutics company profile →
BioFluidica Logo

BioFluidica

HQ: United States Website
  • Description: Provider of a biotechnology diagnostic platform and automated liquid biopsy microfluidic system to isolate and enrich rare biomarkers—circulating tumor cells, exosomes, and trophoblasts—from body fluids; offers exosome and CTC isolation for research and cbNIPT, plus the B³ Blood Collection Tube for room-temperature whole blood shipping with buffer to inhibit micro-clotting.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioFluidica company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Molecular Assemblies

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Molecular Assemblies

2.2 - Growth funds investing in similar companies to Molecular Assemblies

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Molecular Assemblies

4.2 - Public trading comparable groups for Molecular Assemblies

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Molecular Assemblies

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Molecular Assemblies

What does Molecular Assemblies do?

Molecular Assemblies is a provider of proprietary Fully Enzymatic Synthesis (FES) technology to produce long, pure, accurate DNA up to 400 nucleotides without post-synthesis purification; custom DNA oligos for CRISPR, cloning and NGS; gene editing, protein engineering and gene assembly services; and a partnering program licensing FES for on-site synthesis with an automated platform, proprietary reagents and research-use licenses.

Who are Molecular Assemblies's competitors?

Molecular Assemblies's competitors and similar companies include Nightingale Health, Constellation Pharmaceuticals, BC Platforms, Sangamo Therapeutics, and BioFluidica.

Where is Molecular Assemblies headquartered?

Molecular Assemblies is headquartered in United States.

How many employees does Molecular Assemblies have?

Molecular Assemblies has 1,000 employees 🔒.

When was Molecular Assemblies founded?

Molecular Assemblies was founded in 2010 🔒.

What sector and industry vertical is Molecular Assemblies in?

Molecular Assemblies is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Molecular Assemblies

Who are the top strategic acquirers in Molecular Assemblies's sector and industry

Top strategic M&A buyers and acquirers in Molecular Assemblies's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Molecular Assemblies?

Top strategic M&A buyers groups and sectors for Molecular Assemblies include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Molecular Assemblies's sector and industry vertical

Which are the top PE firms investing in Molecular Assemblies's sector and industry vertical?

Top PE firms investing in Molecular Assemblies's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Molecular Assemblies's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Molecular Assemblies's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Molecular Assemblies's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Molecular Assemblies include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Molecular Assemblies's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Molecular Assemblies?

The key public trading comparables and valuation benchmarks for Molecular Assemblies include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Molecular Assemblies for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Molecular Assemblies with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Molecular Assemblies's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Molecular Assemblies with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Molecular Assemblies's' sector and industry vertical?

Access recent funding rounds and capital raises in Molecular Assemblies's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Molecular Assemblies

Launch login modal Launch register modal